Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 16, 2014, Pages 6881-6885

  Yildirim, Mem Arjen ^a   Seckin, Kerem Doga ^a   Togrul, Cihan ^a   Baser, Eralp ^a   Karsli, Mehmet Fatih ^a   Gungor, Tayfun ^a   Gulerman, Hacer Cavidan ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CA 125; Neutrophil lymphocyte ratio; Ovarian mass; Platelet lymphocyte ratio

Indexed keywords

CA 125 ANTIGEN;

BASOPHIL; BLOOD; CYTOLOGY; EARLY DIAGNOSIS; EOSINOPHIL; FEMALE; HUMAN; LYMPHOCYTE; LYMPHOCYTE COUNT; NEUTROPHIL; OVARIAN NEOPLASMS; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOCYTE COUNT;

BASOPHILS; BLOOD PLATELETS; CA-125 ANTIGEN; EARLY DETECTION OF CANCER; EOSINOPHILS; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; NEUTROPHILS; OVARIAN NEOPLASMS; PLATELET COUNT; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84928566755     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.16.6881     Document Type: Article

References (37)

1. Altinoz MA, Korkmaz R (2004). NF-κB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen-and NSAID-prevention of the ovarian cancer. Neoplasma, 51, 239-47.
2. Ardies CM (2003). Inflammation as cause for scar cancers of the lung. Integr Cancer Ther, 2, 238-46.
3. Arun-Muthuvel V, Jaya V (2014). Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound. Asian Pac J Cancer Prev, 15, 2929-32.
4. Asher V, Lee J, Innamaa A, Bali A (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503.
5. Ashrafgangooei T, Rezaeezadeh M (2011). Risk of malignancy index in preoperative evaluation of pelvic masses. Asian Pac J Cancer Prev, 12, 1727-30.
6. Bartsch H, Nair J (2004). Oxidative stress and lipid peroxidationderived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect Prev, 28, 385-91.
7. Bast RC, Jr. Badgwell D, Lu Z, et al (2005). New tumor markers: CA125 and beyond. Int J Gynecol Cancer, 15, 274-81.
8. Bast RC, Jr Xu FJ, Yu YH, et al (1998). CA 125: the past and the future. Int J Biol Markers, 13, 179-87.
9. Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet, 70, 209-62.
10. Bian J, Li B, Kou XJ, Liu TZ, Ming L (2013). Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer. Asian Pac J Cancer Prev, 14, 6241-3.
11. Brower V (2005). Feeding the flame: new research adds to role of inflammation in cancer development. J Natl Cancer Inst, 97, 251-3.
12. Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23.
13. Cho S, Cho H, Nam A, et al (2008). Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril, 90, 2073-9.
14. Crasta JA, Premlatha TS, Krishnan SM, Vallikad E, Rameshkumar K (2010). Significance of preoperative thrombocytosis in epithelial ovarian cancer. Indian J Pathol Microbiol, 53, 54-6.
15. Dirican A, Kucukzeybek Y, Erten C, et al (2013). Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha. Asian Pac J Cancer Prev, 14, 2101-5.
16. Gadducci A, Cosio S, Tana R, Genazzani AR (2009). Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol, 69, 12-27.
17. Guzel AI, Kokanali MK, Erkilinc S, et al (2014). Predictive role of the neutrophil lymphocyte ratio for invasion with gestational trophoblastic disease. Asian Pac J Cancer Prev, 15, 4203-06.
18. Hussein MR, Ahmed RA (2005). Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pretumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther, 4, 819-21.
19. Jaiswal M, Larusso NF, Gores GJ (2001). Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol, 281, 626-34.
20. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
21. Jilma B, Blann A, Pernerstorfer T, et al (1999). Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med, 159, 857-63.
22. Karaman H, Karaman A, Erden A, et al (2013) Relationship between colonic polyp type and the neutrophil/lymphocyte ratio as a biomarker. Asian Pac J Cancer Prev, 14, 3159-61.
23. Kim HS, Han KH, Chung HH, et al (2010). Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol, 36, 691-8.
24. Kuyumcuoglu U, Guzel AI, Celik Y, Erdemoglu M (2010). The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynaecol Oncol, 31, 514-6.
25. Landis SH, Murray T, Bolden S, Wingo PA (1998). Cancer statistics, 1998. CA Cancer J Clin, 48, 6-29.
26. Lee M, Kim SW, Nam EJ, et al (2011). The impact of pretreatment thrombocytosis, persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol, 122, 238-41.
27. Lee YY, Choi CH, Kim HJ, et al (2012). Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res, 32, 1555-61.
28. Li AJ, Madden AC, Cass I, et al (2004). The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol, 92, 211-4.
29. Li L, Xu Y, Yu CX (2012). Proteomic analysis of serum of women with elevated Ca-125 to differentiate malignant from benign ovarian tumors. Asian Pac J Cancer Prev, 13, 3265-70.
30. Pauler DK, Menon U, Mcintosh M, et al (2001). Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev, 10, 489-93.
31. Suh DH, Kim HS, Chung HH, et al (2012). Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol, 162, 206-10.
32. Thavaramara T, Phaloprakarn C, Tangjitgamol S, Manusirivithaya S (2011). Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 94, 871-7.
33. Ueno H, Hawrylowicz CM, Banchereau J (2007). Immunological intervention in human diseases. J Transl Med, 5, 59.
34. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.
35. Van Der Auwera I, Van Laere SJ, Van Den Eynden GG, et al (2004). Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res, 10, 7965-71.
36. Wang W, Bergh A, Damber JE (2004). Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate, 61, 60-72.
37. Winarto H, Laihad BJ, Nuranna L (2014). Modification of cutoff values for HE4, CA125, the risk of malignancy index and the risk of malignancy algorithm for ovarian cancer detection in Jakarta, Indonesia. Asian Pac J Cancer Prev, 15, 1949-53.